Holguín H1, Raigosa D2, Bravo E3, Salazar E4
1 Químico farmacéutico. Clínica Medellín S.A. Grupo de Investigación Promoción y Prevención Farmacéutica. Universidad de Antioquia (Colombia)
2 Tecnóloga en Regencia de Farmacia. Universidad de Antioquia (Colombia)
3 Química farmacéutica. Clínica Medellín S.A. (Colombia)
4 PhD en Ciencias Farmacéuticas y Alimentarias, Línea Atención Farmacéutica. Grupo de Investigación en Tecnología en Regencia de Farmacia. Universidad de Antioquia (Colombia)
Fecha de recepción: 14/06/2018 – Fecha de aceptación: 22/10/2018
Correspondencia: Héctor Holguín w Universidad de Antioquia w Calle 67 Número 53 – 108 Bloque 2, oficina 2-118 w Medellín (Colombia)
hector_holguin30@hotmail.com
____
Summary
Introduction: The underreporting of adverse events is considered as a limitation for the optimal development of these patient safety programs. Strategies such as IHI Global Trigger Tools allow the detection of adverse drug events from trigger drugs tracking as an active search strategy for intrahospital adverse events.
Objective: To evaluate the efficiency of the use of trigger drugs in the detection of adverse events in a non-oncological hospitalization unit of a tertiary healthcare.
Method: An observational study was carried out using as a population all patients with the prescription of at least one of the drugs established as a trigger.
Results: 144 prescriptions of trigger drugs were reported, of which 30% allowed the identification of adverse drug events, with antibiotics (36%) and nonsteroidal anti-inflammatory drugs (23%) being the therapeutic groups with the highest incidence.
Conclusion: The tracking of trigger drugs is an efficient system as a complement in the patient safety programs, It´s necessary to establish the efficiency of each of the trigger drugs considered in this study and some particularities that would facilitate the implementation in others hospitals.
Key words: Hospital Pharmaceutic Service, adverse drug events, adverse drug reactions.
____